Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations is a research paper published in Frontiers in Medicine (2021). On theSindex it has a DataRank of 0.489. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology βNational Institutes of Health
Grant: 1R37CA238274-01A1
Restoring Progestin Sensitivity in Endometrial Cancer
National Institutes of Health
Grant: 5R01CA184101-02
MTDH regulates Fanconi anemia repair pathway to mediate drug resistance
National Institutes of Health
Grant: 1P30CA086862-01
Core--Clinical trials support group
FWCI
1.30
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals